This inventor holds 3 USPTO granted patents. Top assignee: Suntory Limited. Active years: 1992-2001.
Company Filing History:
Years Active: 1992-2001
Title: Innovations by Shinzo Oikawa
Introduction
Shinzo Oikawa is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of methods for screening compounds that can regulate important biological processes. With a total of 3 patents to his name, Oikawa's work has the potential to impact treatments for various medical conditions.
Latest Patents
One of Oikawa's latest patents is a method for screening compounds that regulate the expression of human-inducible nitric oxide synthase. In this innovative approach, a plasmid was constructed where the hiNOS structural gene was replaced with the luciferase structural gene as a reporter gene. This modification retained the functions of the hiNOS gene's 5′-promoter region and 3′-untranslated region. The plasmid was stably transfected into human cell lines, allowing the transformed cells to selectively express the reporter gene in the presence of inducers. This method enables high-sensitivity screening of compounds that may be useful for treating inflammations and sepsis by suppressing hiNOS expression, as well as compounds that could aid in antitumor, antiviral, and vascular restenosis prevention treatments through hiNOS induction.
Another significant patent by Oikawa focuses on a method for inhibiting the metastasis of colon cancer to the liver. This invention addresses a critical challenge in cancer treatment, aiming to improve patient outcomes by preventing the spread of cancerous cells.
Career Highlights
Shinzo Oikawa is currently associated with Suntory Limited, a company known for its commitment to innovation and research in various fields. His work at Suntory has allowed him to explore and develop groundbreaking methods that contribute to medical science.
Collaborations
Oikawa has collaborated with esteemed colleagues such as Shoji Tanaka and Hiroshi Nakazato. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the biomedical sector.
Conclusion
Shinzo Oikawa's contributions to the field of biomedical research through his patents demonstrate his commitment to advancing medical science. His innovative methods have the potential to lead to significant improvements in treatment options for various health conditions.